1 |
Endovenous Laser Ablation Treatment for Lower Extremity Ulcers Associated With Livedoid Vasculopathy.
61
|
Chow M...Wysong A
|
30882502 |
2020 |
2 |
Unraveling the mystery of Covid-19 Cytokine storm: From skin to organ systems.
61
|
Garg S...Agarwal R
|
32559324 |
2020 |
3 |
A 75-year-old woman with primary antiphospholipid syndrome presenting with livedoid vasculopathy.
61
|
He H...Wu N
|
32359084 |
2020 |
4 |
Successful Treatment of Painful Cutaneous Vasculopathy With Rivaroxaban in a Patient With Systemic Lupus Erythematosus.
61
|
Leisenring NH...Marano AL
|
32484618 |
2020 |
5 |
Livedoid Vasculopathy Associated with Antiphospholipid Antibody Presenting with Leg Ulcer.
61
|
Kapur SV...Oswal JS
|
32451825 |
2020 |
6 |
Livedoid vasculopathy in Koreans: clinical features and response to rivaroxaban treatment.
61
|
Lee JS...Cho S
|
31793049 |
2020 |
7 |
Intravenous immunoglobulin in resistant livedoid vasculopathy: Analysis of a case series.
61
|
Ozden MG...Senturk N
|
31965687 |
2020 |
8 |
Livedoid vasculopathy in a patient with bullous pemphigoid and primary Sjögren's syndrome.
61
|
Garcia Briz MI...Mateu Puchades A
|
29526676 |
2020 |
9 |
Efficacy of an anti-TNF-alpha agent in refractory livedoid vasculopathy: a retrospective analysis.
61
|
Gao Y...Jin H
|
32116074 |
2020 |
10 |
ADA2 Deficiency: Case Series of Five Patients with Varying Phenotypes.
61
|
Tanatar A...Aktay Ayaz N
|
31848804 |
2020 |
11 |
Recognition and Management of Cutaneous Polyarteritis Nodosum Versus Livedoid Vasculitis: A Case Report.
61
|
Forbes J...Villacorta M
|
32140348 |
2020 |
12 |
Chronic leg ulcerations associated with livedoid vasculopathy successfully treated with rivaroxaban.
61
|
Miguel D...Goetze S
|
30767258 |
2020 |
13 |
Livedoid vasculopathy presenting with leg ulcers.
61
|
Kumar A...Agarwal A
|
31220328 |
2019 |
14 |
Vasculitic mononeuritis multiplex associated with livedoid vasculopathy.
61
|
Corral I...Pian H
|
31771777 |
2019 |
15 |
Livedoid vasculopathy: how to diagnose and how to treat?
61
|
Lipsker D
|
31468610 |
2019 |
16 |
Characteristics, risk factors and treatment reality in livedoid vasculopathy - a multicentre analysis.
61
|
Weishaupt C...Goerge T
|
31009111 |
2019 |
17 |
Is there a role for hyperbaric oxygen therapy in the treatment of refractory wounds of rare etiology?
61
|
Longobardi P...Bennett MH
|
31523797 |
2019 |
18 |
Topical becaplermin gel is an effective adjuvant for long-standing ulcers of livedoid vasculopathy recalcitrant to anticoagulant therapy.
61
|
Mushtaq S...Mudugal R
|
30706539 |
2019 |
19 |
Retiform non-blanchable purpuric plaques in a patient with systemic lupus erythematosus.
61
|
Grinnell M...Hearth-Holmes M
|
31126212 |
2019 |
20 |
Livedoid vasculopathy: does hyperhomocysteinaemia play an aetiological role?
61
|
Marsch WC...Hoffmann K
|
31389788 |
2019 |
21 |
Prevention of recurrent ulceration of livedoid vasculopathy with long-term apixaban monotherapy.
61
|
Osada SI...Manabe M
|
30156315 |
2019 |
22 |
Atypical Mycobacterial Infection Arising Amid Corticosteroid Therapy for Livedoid Vasculopathy.
61
|
Edminister JR...Gottwald LD
|
31687220 |
2019 |
23 |
Systemic lupus erythematosus with refractory ulcerated livedoid vasculopathy: Successful treatment with intravenous immunoglobulin and warfarin.
61
|
Yoshioka K...Chen KR
|
30455888 |
2018 |
24 |
Livedoid Vasculopathy: A French Observational Study Including Therapeutic Options.
61
|
Gardette E...Barete S
|
29738044 |
2018 |
25 |
Traditional Korean medicine treatment for livedoid vasculopathy: Five case reports.
61
|
Lee JA...Park S
|
30100128 |
2018 |
26 |
Livedoid Vasculopathy Presenting in a Patient With Sickle Cell Disease.
61
|
Reagin H...Susa J
|
29533274 |
2018 |
27 |
Dermoscopy of early non-ulcerated livedoid vasculopathy.
61
|
Wollina U
|
30244265 |
2018 |
28 |
Livedoid vasculopathy: a compelling diagnosis.
61
|
Freitas TQ...Criado PR
|
30101138 |
2018 |
29 |
Systemic therapies for leg ulcers.
61
|
Dissemond J...Reich-Schupke S
|
29989361 |
2018 |
30 |
The management of livedoid vasculopathy focused on direct oral anticoagulants (DOACs): four case reports successfully treated with rivaroxaban.
61
|
Franco Marques G...Cajas Garcia MS
|
29663354 |
2018 |
31 |
Three cases of lymphocytic thrombophilic arteritis presenting with an annular eruption.
61
|
Kelly RI...Williams RA
|
28752544 |
2018 |
32 |
Treatment of Livedoid Vasculopathy With Rivaroxaban: A Potential Use of New Oral Anticoagulants for Dermatologists.
61
|
Jimenez-Gallo D...Linares-Barrios M
|
29074145 |
2018 |
33 |
Ulcerative livedoid vasculopathy responding to clopidogrel.
61
|
Kunzler E...Chong BF
|
29892667 |
2018 |
34 |
Treatment for Livedoid Vasculopathy: A Systematic Review.
61
|
Micieli R...Alavi A
|
29141075 |
2018 |
35 |
Systemic Lupus Erythematosus Presenting as Livedoid Vasculopathy over the Forearms.
61
|
Yadav P...Singh D
|
29911533 |
2018 |
36 |
Vasculopathies, cutaneous necrosis and emergency in dermatology.
61
|
Martinez-Mera C...Llamas-Velasco M
|
28845953 |
2017 |
37 |
Prevention of livedoid vasculopathy recurrence by prolonged administration of rivaroxaban.
61
|
Drerup C...Goerge T
|
28609556 |
2017 |
38 |
Analysis of serum levels and cutaneous expression of lipoprotein (a) in 38 patients with livedoid vasculopathy.
61
|
Espinel DPGS...Criado PR
|
28901563 |
2017 |
39 |
Analysis of the German DRG data for livedoid vasculopathy and calciphylaxis.
61
|
Renner R...Erfurt-Berge C
|
28252815 |
2017 |
40 |
Livedoid Vasculopathy.
61
|
Zampeli E...Moutsopoulos HM
|
28511282 |
2017 |
41 |
Occlusive Nonvasculitic Vasculopathy.
61
|
Llamas-Velasco M...Requena L
|
27759698 |
2017 |
42 |
Use of Low-dose Oral Warfarin in Three Cases of Livedoid Vasculopathy.
61
|
Saoji V...Madke B
|
28979014 |
2017 |
43 |
Efficacy of new low-dose oral anticoagulants in recalcitrant livedoid vasculopathy.
61
|
Furukawa F...Shimizu T
|
28739563 |
2017 |
44 |
Enhanced mRNA expression of plasminogen activator inhibitor-1 in livedoid vasculopathy lesions.
61
|
Agirbasli M...Akkiprik M
|
28186689 |
2017 |
45 |
[Livedoid vasculopathy secondary to coeliac disease].
61
|
Henry J...Valois A
|
28283193 |
2017 |
46 |
Dabigatran in the management of livedoid vasculopathy.
61
|
Sawada T...Suehiro M
|
28052437 |
2017 |
47 |
Dermoscopic features of livedoid vasculopathy.
61
|
Hu SC...Lin YS
|
28296736 |
2017 |
48 |
Vasculitic and autoimmune wounds.
61
|
Shanmugam VK...McNish S
|
28214498 |
2017 |
49 |
Livedoid vasculopathy and popliteal artery occlusion in a patient with protein S deficiency.
61
|
Nakayama T...Watanabe D
|
27774697 |
2017 |
50 |
Fast Cicatrization of Extensive Livedoid Vasculopathy Ulcers under Treatment with Sildenafil.
61
|
Lopes LM...Bredemeier M
|
28223767 |
2017 |